Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Beta Urogastrone
2. Beta-urogastrone
3. Egf
4. Epidermal Growth Factor-urogastrone
5. Growth Factor, Epidermal
6. Growth Factor-urogastrone, Epidermal
7. Human Urinary Gastric Inhibitor
8. Urogastrone
1. 62229-50-9
2. Gastrone, Uro-
3. Uroanthelone
4. Uroenterone
5. Urogastron
6. Urogastrone
7. Kutrol
8. Beta-urogastrone
9. Anthelone U
10. Urogastrone [jan]
11. Gastrone, Gamma-uro-
12. Gastrone, Beta-uro- (human)
13. Epidermal Growth Factor (egf)
14. Ccris 7234
15. Einecs 263-468-7
16. Epidermal Growth Factor-urogastrone
Molecular Weight | 6046 g/mol |
---|---|
Molecular Formula | C257H381N73O83S7 |
XLogP3 | -19.6 |
Hydrogen Bond Donor Count | 96 |
Hydrogen Bond Acceptor Count | 96 |
Rotatable Bond Count | 193 |
Exact Mass | 6043.5948607 g/mol |
Monoisotopic Mass | 6041.5881511 g/mol |
Topological Polar Surface Area | 2560 Ų |
Heavy Atom Count | 420 |
Formal Charge | 0 |
Complexity | 15400 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 51 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
37
PharmaCompass offers a list of Epidermal Growth Factor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Epidermal Growth Factor manufacturer or Epidermal Growth Factor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Epidermal Growth Factor manufacturer or Epidermal Growth Factor supplier.
PharmaCompass also assists you with knowing the Epidermal Growth Factor API Price utilized in the formulation of products. Epidermal Growth Factor API Price is not always fixed or binding as the Epidermal Growth Factor Price is obtained through a variety of data sources. The Epidermal Growth Factor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Urogastron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Urogastron, including repackagers and relabelers. The FDA regulates Urogastron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Urogastron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Urogastron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Urogastron supplier is an individual or a company that provides Urogastron active pharmaceutical ingredient (API) or Urogastron finished formulations upon request. The Urogastron suppliers may include Urogastron API manufacturers, exporters, distributors and traders.
click here to find a list of Urogastron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Urogastron DMF (Drug Master File) is a document detailing the whole manufacturing process of Urogastron active pharmaceutical ingredient (API) in detail. Different forms of Urogastron DMFs exist exist since differing nations have different regulations, such as Urogastron USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Urogastron DMF submitted to regulatory agencies in the US is known as a USDMF. Urogastron USDMF includes data on Urogastron's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Urogastron USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Urogastron suppliers with USDMF on PharmaCompass.
Urogastron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Urogastron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Urogastron GMP manufacturer or Urogastron GMP API supplier for your needs.
A Urogastron CoA (Certificate of Analysis) is a formal document that attests to Urogastron's compliance with Urogastron specifications and serves as a tool for batch-level quality control.
Urogastron CoA mostly includes findings from lab analyses of a specific batch. For each Urogastron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Urogastron may be tested according to a variety of international standards, such as European Pharmacopoeia (Urogastron EP), Urogastron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Urogastron USP).